Correlation Between Hookipa Pharma and Verve Therapeutics
Can any of the company-specific risk be diversified away by investing in both Hookipa Pharma and Verve Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hookipa Pharma and Verve Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hookipa Pharma and Verve Therapeutics, you can compare the effects of market volatilities on Hookipa Pharma and Verve Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hookipa Pharma with a short position of Verve Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hookipa Pharma and Verve Therapeutics.
Diversification Opportunities for Hookipa Pharma and Verve Therapeutics
-0.26 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Hookipa and Verve is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Hookipa Pharma and Verve Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verve Therapeutics and Hookipa Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hookipa Pharma are associated (or correlated) with Verve Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verve Therapeutics has no effect on the direction of Hookipa Pharma i.e., Hookipa Pharma and Verve Therapeutics go up and down completely randomly.
Pair Corralation between Hookipa Pharma and Verve Therapeutics
Given the investment horizon of 90 days Hookipa Pharma is expected to under-perform the Verve Therapeutics. In addition to that, Hookipa Pharma is 1.01 times more volatile than Verve Therapeutics. It trades about -0.03 of its total potential returns per unit of risk. Verve Therapeutics is currently generating about -0.02 per unit of volatility. If you would invest 2,001 in Verve Therapeutics on September 26, 2024 and sell it today you would lose (1,424) from holding Verve Therapeutics or give up 71.16% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Hookipa Pharma vs. Verve Therapeutics
Performance |
Timeline |
Hookipa Pharma |
Verve Therapeutics |
Hookipa Pharma and Verve Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Hookipa Pharma and Verve Therapeutics
The main advantage of trading using opposite Hookipa Pharma and Verve Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hookipa Pharma position performs unexpectedly, Verve Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verve Therapeutics will offset losses from the drop in Verve Therapeutics' long position.Hookipa Pharma vs. Mereo BioPharma Group | Hookipa Pharma vs. Terns Pharmaceuticals | Hookipa Pharma vs. PDS Biotechnology Corp | Hookipa Pharma vs. Inozyme Pharma |
Verve Therapeutics vs. Fate Therapeutics | Verve Therapeutics vs. Caribou Biosciences | Verve Therapeutics vs. Karyopharm Therapeutics | Verve Therapeutics vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |